Not Yet Classified

This recall has not yet been classified by risk level.

Merck Recalls Temodar and Temozolomide Bottles with Cracked Caps Due to Failure to Meet Child-Resistant Closure Requirement

Date: August 18, 2015
Company: Merck Sharp & Dohme Corp., of Whitehouse Station, N.J.
Status: Ongoing
Source: CPSC

What You Should Do

Stop using this product immediately. Do not consume, use, or distribute it.

Consumers should immediately inspect their bottle caps for cracks. If a crack is found, consumers should contact Merck for a replacement cap. As with all drug products, the bottles should be stored up high, out of sight and reach of young children. Consumers may continue to use the drug as directed. Options: Replace

Affected Products

This recall to replace involves bottle caps for Temodar and Temozolomide (generic) capsules, an oral chemotherapy drug. The capsules were distributed in 5- and 14-count brown glass bottles that have white plastic child-resistant caps. A white label affixed to the bottle has the word "Temozolomide" printed in black lettering.

Why Was This Recalled?

The bottle cap can be cracked which can cause the child-resistant closure to become ineffective to young children who can gain unintended access to the capsules, posing a risk of poisoning.

Where Was This Sold?

Distribution information not available.

About Merck Sharp & Dohme Corp., of Whitehouse Station, N.J.

Merck Sharp & Dohme Corp., of Whitehouse Station, N.J. has 1 total recall tracked by RecallDetector.

Related Recalls

Data sourced from the CPSC. Last updated March 26, 2026. View original report